← Back to the library

Semaglutide

A GLP-1 receptor agonist

Established clinical use
Illustrative bottle labeled Semaglutide, glp-1 medicineILLUSTRATION · NOT A PRODUCT

A peptide-based prescription medicine with FDA-approved products for specific conditions.

What it is

Semaglutide acts on the GLP-1 receptor. FDA-approved products have specific indications, formulations, and labeling.

What the evidence says

Clinical trials support approved uses, including type 2 diabetes and, for certain products and patients, chronic weight management.

What remains uncertain

Evidence for an approved product does not automatically apply to an unapproved formulation, a different dose, or a different population.

Primary sources

This page is for education only. It is not medical advice, a treatment recommendation, or a guide to obtaining or using a peptide. Speak with a qualified clinician about personal health decisions.